Related Experiment Video
Updated: May 31, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Caspase-1 promiscuity is counterbalanced by rapid inactivation of processed enzyme
John G Walsh1, Susan E Logue, Alexander U Lüthi
1Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland.
Abstract:
Members of the caspase family of cysteine proteases coordinate the highly disparate processes of apoptosis and inflammation. However, although hundreds of substrates for the apoptosis effector caspases (caspase-3 and caspase-7) have been identified, only two confirmed substrates for the key inflammatory protease (caspase-1) are known. Whether this reflects intrinsic differences in the substrate specificity of inflammatory versus apoptotic caspases or their relative abundance in vivo is unknown. To address this issue, we have compared the specificity of caspases-1, -3, and -7 toward peptide and protein substrates. Contrary to expectation, caspase-1 displayed concentration-dependent promiscuity toward a variety of substrates, suggesting that caspase-1 specificity is maintained by restricting its abundance. Although endogenous concentrations of caspase-1 were found to be similar to caspase-3, processed caspase-1 was found to be much more labile, with a half-life of ~9 min. This contrasted sharply with the active forms of caspase-3 and caspase-7, which exhibited half-lives of 8 and 11 h, respectively. We propose that the high degree of substrate specificity displayed by caspase-1 is maintained through rapid spontaneous inactivation of this protease.
Insights
Caspase-1, crucial for inflammation, shows broad substrate activity but is rapidly inactivated. This instability, not specificity, likely explains its limited known substrates, unlike stable caspases-3 and -7.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Caspases are cysteine proteases regulating apoptosis and inflammation.
- Apoptosis effector caspases (caspase-3, -7) have many substrates, while inflammatory caspase-1 has few known substrates.
- The reason for caspase-1's limited substrate identification is unclear.
Purpose of the Study:
- To compare the substrate specificity of inflammatory caspase-1 with apoptotic caspases (-3, -7).
- To investigate whether substrate specificity differences or protein stability explain caspase-1's limited substrate repertoire.
Main Methods:
- Compared substrate specificity of caspases-1, -3, and -7 using peptide and protein substrates.
- Measured endogenous concentrations of caspases.
- Determined the half-lives of active caspase-1, -3, and -7.
Main Results:
- Caspase-1 exhibited concentration-dependent promiscuity towards various substrates.
- Endogenous concentrations of caspase-1 and caspase-3 were similar.
- Active caspase-1 was rapidly degraded (half-life ~9 min) compared to caspase-3 (~8 h) and caspase-7 (~11 h).
Conclusions:
- Caspase-1's substrate specificity is maintained by its rapid inactivation, not inherent specificity.
- The lability of processed caspase-1 limits its activity and substrate interactions in vivo.
- This contrasts with the stability and broad substrate interactions of effector caspases.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Extrinsic Apoptotic Pathway

